Comparison of whole cell expression profiles between LEN-sensitive HuT102 and LEN-resistant OATL4 after LEN treatment provided additional supporting evidence of how LEN exerts its anti-tumor effects against ATL cells. Here, SLC22A12 is linked to neoplasm.